Home LiquidLung

LiquidLung

In operation
-
Developer of Pulmonary Disease Detection, Diagnosis, and Treatment Technologies
Basic
Enterprise Profile

Basic Information

LiquidLung is committed to fundamentally improving the detection, diagnosis, and treatment of lung diseases. LiquidLung's flagship LIQUIDLUNGDx liquid biopsy program for lung cancer has unique advantages to address clinically urgent unmet needs throughout the entire lung cancer treatment process.
LiquidLung, Inc.
United States of America
less than 15 people
January 01, 2018
--

Enterprise Profile

Industrial Sector
Medical Device R&D and Design # Diagnostic Manufacturing
Concept
Laboratory Diagnosis Lung Cancer
Application Scenarios
Medical Device Consumables